Thoratec left ventricular assist device for bridging to recovery in fulminant acute myocarditis

Joharchi, Masood S; Neiser, Uwe; Lenschow, U.; Schubert, Jochen K.; Kienast, W.; Noeldge-Schomburg, Gabriele; Steinhoff, Gustav

doi:10.1016/s0003-4975(02)03542-7

Cited by 19 publications

(8 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These indications are in flux. 2,8,12,13,15,19,[21][22][23][24][25][26][27] The definitive cause of the acute fulminant myocarditis remains unproven, but we suspect it was related to pulmonary Aspergillus. During VAD placement, we did not obtain a myocardial biopsy specimen because of the inflamed and friable myocardium in the presence of a profound coagulopathy.…”

Section: Discussionmentioning

confidence: 99%

Levitronix Ventricular Assist Devices as a Bridge to Recovery After Profound Biventricular Heart Failure Associated With Pulmonary Aspergillosis

Whitson

D’Cunha

Knutsen

et al. 2007

The Journal of Heart and Lung Transplantation

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Levitronix Ventricular Assist Devices as a Bridge to Recovery After Profound Biventricular Heart Failure Associated With Pulmonary Aspergillosis

Whitson

D’Cunha

Knutsen

et al. 2007

The Journal of Heart and Lung Transplantation

View full text Add to dashboard Cite

“…[104][105][106]109,110 One patient supported with a Thoratec LVAD was reported to be in NYHA Class I at follow-up (6 months) in the case report by Joharchi and colleagues. 107 This patient had recovered from acute myopericarditis and had been weaned from her LVAD after 46 days.…”

Section: First-generation Devicesmentioning

confidence: 96%

“…Where a component is considered not to be relevant to a study design, it is referred to as not applicable (N/A). 107 report survival for one 17-year-old patient with acute myopericarditis. The patient was successfully weaned from support after 46 days, and was alive 6 months following explantation.…”

Section: Second-generation Lvadsmentioning

confidence: 97%

“…All the studies assessed firstgeneration devices with one case report of the Abiomed LVAD, 104 one case report of the HeartMate LVAD, 105 one case report of the Novacor LVAD 106 , two case reports of the Thoratec LVAD, 107,108 and two case series evaluations of the Toyobo LVAD. 109,110 There were no studies of second-generation devices included in the systematic review.…”

Section: Quantity Of Researchmentioning

confidence: 99%

See 1 more Smart Citation

Cost–effectiveness of left ventricular-assist devices in end-stage heart failure

Hutchinson¹,

Scott²,

Clegg³

et al. 2008

Expert Review of Cardiovascular Therapy

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTAThe clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation NHS R&D HTA ProgrammeT he research findings from the NHS R&D Health Technology Assessment (HTA) Programme directly influence key decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC) who rely on HTA outputs to help raise standards of care. HTA findings also help to improve the quality of the service in the NHS indirectly in that they form a key component of the 'National Knowledge Service' that is being developed to improve the evidence of clinical practice throughout the NHS.The HTA Programme was set up in 1993. Its role is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care.The HTA Programme commissions research only on topics...

show abstract

“…Successful weaning from VAD with recovery of ventricular function in fulminant myocarditis has been described. [57][58][59][60][61][62][63][64] Moreover, VAD may serve as a bridge to myocardial recovery or transplantation. 65,66 A case series of 5 patients supported with VAD for fulminant myocarditis (age 15-55 years) has been reported.…”

Section: Ventricular Assist Devices and Myocarditismentioning

confidence: 99%

Transplantation for Myocarditis: A Controversy Revisited

Moloney

Egan

Kelly

et al. 2005

The Journal of Heart and Lung Transplantation

View full text Add to dashboard Cite

Thoratec left ventricular assist device for bridging to recovery in fulminant acute myocarditis

Cited by 19 publications

References 8 publications

Levitronix Ventricular Assist Devices as a Bridge to Recovery After Profound Biventricular Heart Failure Associated With Pulmonary Aspergillosis

Levitronix Ventricular Assist Devices as a Bridge to Recovery After Profound Biventricular Heart Failure Associated With Pulmonary Aspergillosis

Cost–effectiveness of left ventricular-assist devices in end-stage heart failure

Transplantation for Myocarditis: A Controversy Revisited

Contact Info

Product

Resources

About